X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
33
PharmaCompass offers a list of Hydroxyprogesterone Caproate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxyprogesterone Caproate manufacturer or Hydroxyprogesterone Caproate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxyprogesterone Caproate manufacturer or Hydroxyprogesterone Caproate supplier.
PharmaCompass also assists you with knowing the Hydroxyprogesterone Caproate API Price utilized in the formulation of products. Hydroxyprogesterone Caproate API Price is not always fixed or binding as the Hydroxyprogesterone Caproate Price is obtained through a variety of data sources. The Hydroxyprogesterone Caproate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 17.alpha.-Hydroxyprogesterone n-caproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17.alpha.-Hydroxyprogesterone n-caproate, including repackagers and relabelers. The FDA regulates 17.alpha.-Hydroxyprogesterone n-caproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17.alpha.-Hydroxyprogesterone n-caproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17.alpha.-Hydroxyprogesterone n-caproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17.alpha.-Hydroxyprogesterone n-caproate supplier is an individual or a company that provides 17.alpha.-Hydroxyprogesterone n-caproate active pharmaceutical ingredient (API) or 17.alpha.-Hydroxyprogesterone n-caproate finished formulations upon request. The 17.alpha.-Hydroxyprogesterone n-caproate suppliers may include 17.alpha.-Hydroxyprogesterone n-caproate API manufacturers, exporters, distributors and traders.
click here to find a list of 17.alpha.-Hydroxyprogesterone n-caproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 17.alpha.-Hydroxyprogesterone n-caproate DMF (Drug Master File) is a document detailing the whole manufacturing process of 17.alpha.-Hydroxyprogesterone n-caproate active pharmaceutical ingredient (API) in detail. Different forms of 17.alpha.-Hydroxyprogesterone n-caproate DMFs exist exist since differing nations have different regulations, such as 17.alpha.-Hydroxyprogesterone n-caproate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 17.alpha.-Hydroxyprogesterone n-caproate DMF submitted to regulatory agencies in the US is known as a USDMF. 17.alpha.-Hydroxyprogesterone n-caproate USDMF includes data on 17.alpha.-Hydroxyprogesterone n-caproate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 17.alpha.-Hydroxyprogesterone n-caproate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 17.alpha.-Hydroxyprogesterone n-caproate suppliers with USDMF on PharmaCompass.
A 17.alpha.-Hydroxyprogesterone n-caproate written confirmation (17.alpha.-Hydroxyprogesterone n-caproate WC) is an official document issued by a regulatory agency to a 17.alpha.-Hydroxyprogesterone n-caproate manufacturer, verifying that the manufacturing facility of a 17.alpha.-Hydroxyprogesterone n-caproate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 17.alpha.-Hydroxyprogesterone n-caproate APIs or 17.alpha.-Hydroxyprogesterone n-caproate finished pharmaceutical products to another nation, regulatory agencies frequently require a 17.alpha.-Hydroxyprogesterone n-caproate WC (written confirmation) as part of the regulatory process.
click here to find a list of 17.alpha.-Hydroxyprogesterone n-caproate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17.alpha.-Hydroxyprogesterone n-caproate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17.alpha.-Hydroxyprogesterone n-caproate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17.alpha.-Hydroxyprogesterone n-caproate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17.alpha.-Hydroxyprogesterone n-caproate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17.alpha.-Hydroxyprogesterone n-caproate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17.alpha.-Hydroxyprogesterone n-caproate suppliers with NDC on PharmaCompass.
17.alpha.-Hydroxyprogesterone n-caproate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 17.alpha.-Hydroxyprogesterone n-caproate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 17.alpha.-Hydroxyprogesterone n-caproate GMP manufacturer or 17.alpha.-Hydroxyprogesterone n-caproate GMP API supplier for your needs.
A 17.alpha.-Hydroxyprogesterone n-caproate CoA (Certificate of Analysis) is a formal document that attests to 17.alpha.-Hydroxyprogesterone n-caproate's compliance with 17.alpha.-Hydroxyprogesterone n-caproate specifications and serves as a tool for batch-level quality control.
17.alpha.-Hydroxyprogesterone n-caproate CoA mostly includes findings from lab analyses of a specific batch. For each 17.alpha.-Hydroxyprogesterone n-caproate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
17.alpha.-Hydroxyprogesterone n-caproate may be tested according to a variety of international standards, such as European Pharmacopoeia (17.alpha.-Hydroxyprogesterone n-caproate EP), 17.alpha.-Hydroxyprogesterone n-caproate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (17.alpha.-Hydroxyprogesterone n-caproate USP).
Market Place
